Sign In
Buy EMBC
$3.32
-0.170 (-4.87%)
At Close: Jun 03, 2026
embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day
06:30am, Thursday, 22'nd May 2025
PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its ina
Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript
01:39pm, Friday, 09'th May 2025
Embecta Corp. (NASDAQ:EMBC ) Q2 2025 Earnings Conference Call May 9, 2025 8:00 AM ET Company Participants Dev Kurdikar - President & CEO Jake Elguicze - CFO Pravesh Khandelwal - Vice VP, IR Conference
Embecta Corp. (EMBC) Tops Q2 Earnings Estimates
08:40am, Friday, 09'th May 2025
Embecta Corp. (EMBC) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.67 per share a year ago.
Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results
06:30am, Friday, 09'th May 2025
PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six
embecta Announces Quarterly Cash Dividend
06:00am, Friday, 09'th May 2025
PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandin
Embecta to host Analyst and Investor Day on May 22, 2025
07:30am, Monday, 28'th Apr 2025
PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Inves
embecta to Report Fiscal Second Quarter 2025 Financial Results
05:00pm, Monday, 21'st Apr 2025
PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference cal
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations
08:05am, Tuesday, 01'st Apr 2025
PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark
Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour
02:17am, Friday, 28'th Feb 2025
Embecta faces headwinds from new insulin delivery technologies and GLP-1 drugs, but its valuation is compelling with a ~44% free cash flow yield on guided free cashflow. EMBC's end market is expected
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference
05:00pm, Tuesday, 18'th Feb 2025
PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta's Chief Financial Officer, will present at the J.P. Morgan Global
Embecta Corp. (EMBC) Q1 2025 Earnings Call Transcript
01:55pm, Thursday, 06'th Feb 2025
Embecta Corp. (NASDAQ:EMBC ) Q1 2025 Earnings Conference Call February 6, 2025 8:00 AM ET Company Participants Pravesh Khandelwal - Vice President, Investor Relations Dev Kurdikar - President & Chief
Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates
08:45am, Thursday, 06'th Feb 2025
Embecta Corp. (EMBC) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.61 per share a year ago.
Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results
06:30am, Thursday, 06'th Feb 2025
PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month
embecta Announces Quarterly Cash Dividend
06:00am, Thursday, 06'th Feb 2025
PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandi
embecta to Report Fiscal First Quarter 2025 Financial Results
05:00pm, Thursday, 23'rd Jan 2025
PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call
